I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms in Hispanic Individuals
Conditions: Caregiver Burden; Alzheimer Disease Interventions: Behavioral: Brain CareNotes; Behavioral: Dementia Guide Expert Sponsors: Indiana University; National Institute on Aging (NIA) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 25, 2023 Category: Research Source Type: clinical trials
MIMA Pilot Study: MIcrostructure of the Medial Temporal Lobe in Early Alzheimer's Disease
Conditions: Alzheimer Disease, Early Onset Interventions: Diagnostic Test: high-resolution diffusion MRI Sponsors: Rennes University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 25, 2023 Category: Research Source Type: clinical trials
Phase II Clinical Trial of Interleukin-2 in AD
Conditions: Alzheimer Disease Interventions: Drug: Interleukin-2; Drug: Placebo Sponsors: The Methodist Hospital Research Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2023 Category: Research Source Type: clinical trials
Effects of 24-week Computerized Cognitive Training in Patients With MCI and AD
Conditions: Mild Cognitive Impairment; Alzheimer Disease Interventions: Other: Computerized Cognitive Training; Other: Treatment As Usual Sponsors: Chongqing Medical University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2023 Category: Research Source Type: clinical trials
dTMS for Subjective Cognitive Decline
Conditions: Alzheimer Disease; Subjective Cognitive Decline Interventions: Device: Active Brainsway H7-Coil Deep TMS System; Device: Sham Brainsway H7-Coil Deep TMS System; Other: Cognitive Training Sponsors: Rotman Research Institute at Baycrest; Brainsway; Centre for Addiction and Mental Health Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2023 Category: Research Source Type: clinical trials
Improving Memory in Alzheimer's Disease With Noninvasive Brain Stimulation
Conditions: Alzheimer Disease Interventions: Device: High definition transcranial electrical current stimulation Sponsors: Boston University Charles River Campus Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2023 Category: Research Source Type: clinical trials
Clinical Applicantion of Multi-Tracer PET/MR Imaging in Neurological Disorders/Disease
Conditions: Alzheimer Disease; Parkinson Disease; Epilepsy; Malignant Brain Tumor Interventions: Device: PET/MR Sponsors: Xuanwu Hospital, Beijing; Peking University Cancer Hospital& Institute; Shanghai Zhongshan Hospital; Wuhan TongJi Hospital; Henan Provincial People ' s Hospital; Sun Yat-sen University; Shanghai East Hospital of Tongji University; The First Affiliated Hospital with Nanjing Medical University; Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences; Shanghai Jiao Tong University School of Medicine Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 20, 2023 Category: Research Source Type: clinical trials
Study to Evaluate the Efficacy and Safety of ATNC-MDD V1(TMS With Cognitive Training) in Mild Alzheimer's Dementia
Conditions: Alzheimer ' s Disease; Dementia; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Neurodegenerative Diseases; Neurocognitive Disorders; Mental Disorder Interventions: Device: ATNC MDD-V1 (Real TMS + Real Cog); Device: ATNC MDD-V1 (Sham TMS + Real Cog) Sponsors: Advanced Technology& Communications; Chungnam National University Hospital; Korea University Anam Hospital; Dong-A University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2023 Category: Research Source Type: clinical trials
Personalized Obstructive Sleep Apnea Treatment and Effects on Alzheimer's Disease Biomarkers and Cognition Among Blacks
Conditions: Sleep Apnea Interventions: Other: Standard of Care; Behavioral: Personalized OSA Treatment Sponsors: University of Miami; National Institute on Aging (NIA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2023 Category: Research Source Type: clinical trials
Effects of Yeast Beta-glucan on Cognitive Function in Patients With Mild Cognitive Impairment
Conditions: Mild Cognitive Impairment; Alzheimer Disease Interventions: Dietary Supplement: Yeast beta-glucan; Dietary Supplement: Starch Sponsors: Xiaofan Xu Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2023 Category: Research Source Type: clinical trials
Multimodal Deep Learning for the Diagnosis and Assessment of Alzheimer's Disease
Conditions: Alzheimer Disease; Mild Cognitive Impairment Interventions: Diagnostic Test: gait video; speech video; facial expression video; Sponsors: First Hospital of China Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 13, 2023 Category: Research Source Type: clinical trials
ED-LEAD: Emergency Departments Leading the Transformation of Alzheimer's and Dementia Care
Conditions: Alzheimer ' s Disease Related Dementia; Alzheimer Disease Interventions: Behavioral: Emergency Care Redesign (ECR); Behavioral: Nurse-led Telephonic Care (NLTC); Behavioral: Community Paramedic-led Transitions Intervention (CPTI) Sponsors: NYU Langone Health; National Institute on Aging (NIA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2023 Category: Research Source Type: clinical trials
Impact of Therapeutic Plasma Exchange on RNA Biomarker Expression Levels in Alzheimer's Patients
Conditions: Alzheimer Disease Sponsors: MaxWell Clinic, PLC Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2023 Category: Research Source Type: clinical trials
Does BCG Vaccination Reduce Biomarkers of Alzheimer's Disease?
Conditions: Alzheimer Disease, Late Onset Interventions: Biological: BCG vaccine Sponsors: Tamir Ben-Hur; Hebrew University of Jerusalem Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2023 Category: Research Source Type: clinical trials
Efficacy and Safety of GSK4527226 [AL101] in Participants With Early Alzheimer's Disease
Conditions: Alzheimer ' s Disease Interventions: Drug: GSK4527226; Other: Placebo Sponsors: GlaxoSmithKline; Alector Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2023 Category: Research Source Type: clinical trials
